
Treating Hyperkalemia in the Emergency Department

Treating Hyperkalemia in the Emergency Department is organized by Connect Educate Impact (CEI).
Initial Release Date: March 8, 2023
Planned Expiration Date: March 8, 2026
Description:
As a relatively new medication to treat hyperkalemia, the effectiveness of sodium polystyrene sulfonate (SPS) is compared to sodium zirconium cyclosilicate (SZC) in the emergency department in this Journal Club discussion.
Upon successful completion of this application-based course, participants should be able to:
• Review the emergent treatment of hyperkalemia
• Identify the role of cation exchange resins in the emergent treatment of hyperkalemia
• Compare the pharmacology and potassium-lowering efficacy of sodium polystyrene sulfonate (SPS) and sodium zirconium cyclosilicate (SZC)
• Evaluate the strengths, limitations, and results of the SPS vs. SZC study for the treatment of hyperkalemia
• Apply clinical implications of the SPS vs. SZC study to a patient case
Additional details will be posted as soon as information is available.